loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2023_104___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Hubei Biocause Heilen Pharmaceutical Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO., LTD. Jingmen City CN (1)

    filter

    01 Cladribine (1)

    filter

    01 China (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    HUBEI BIOCAUSE HEILEN PHARMACEUTICA...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cladribine

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2023-104 - Rev 00
    Valid
    Chemical
    2024-04-22
    2174
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2023-104 - Rev 00 of Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn

    Looking for Certificates of Suitability (CEPs) for CEP 2023-104 - Rev 00 of Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn 1

    20

    Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Cladribine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-104 - Rev 00

    This Chemical Type CEP, issued on April 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2174 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY